Advertisement

Parenteral Nutrition as an Adjunct to Cancer Therapy

  • S. J. Dudrick
  • E. M. Copeland
  • B. V. MacFadyen
Part of the Klinische Anästhesiologie und Intensivtherapie book series (KAI, volume 13)

Abstract

The purpose of our recent studies has been to define the safety and efficacy of intravenous hyperalimentation (IVH) in the management of malnourished patients with malignant diseases. During a three year period, 406 cancer patients received approximately 2500 calories and 17 g nitrogen daily for 10–147 days (average 23.9 days) as an adjunct to oncologic therapy. Indications for IVH were 43 % chemotherapy, 36 % surgery, 3 % interim nutritional support, 10 % radiation therapy, 6 % enteric fistulas, 2 % leukemia.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    ADIBI, S.A., ALLEN, R.E.. : Impaired jejunal absorption rates of essential amino acids induced by either dietary, caloric or protein deprivation in man. Gastroenterology 59, 404 (1970).PubMedGoogle Scholar
  2. 2.
    ASHCRAFT, K.W., LEAPE, L.: Candida sepsis complicating parenteral feeding. J.A.M.A. 212, 454 (1970).PubMedCrossRefGoogle Scholar
  3. 3.
    BOECKMAN, C.R., KRILL, C.E.: Bacterial and fungal infections complicating parenteral alimentation in infants and children.J. Ped. Surg. 5, 117 (1970).CrossRefGoogle Scholar
  4. 4.
    BOUNOUS, G., GENTILE, J.M., HUGON, J.S.: Elemental diet in the management of intestinal lesions produced by 5-fluorouracil in man. Can. J. Surg. J 4, 312 (1971).Google Scholar
  5. 5.
    BOUNOUS, G., HUGON, J.S., GENTILE, J.M.: Elemental diet in the management of the intestinal lesion produced by 5-fluorouracil in the rat. Can. J. Surg. 14, 298 (1971).PubMedGoogle Scholar
  6. 6.
    BRENNAN, M.F., GOLDMAN, M.H., O’CONNELL, R. C., KUNDSIN, R. B., MOORE, F.D.: Prolonged parenteral alimentation: Candida growth and the prevention of candidemia by amphotericin installation. Ann. Surg. 176, 265 (1972).PubMedCrossRefGoogle Scholar
  7. 7.
    COPELAND, E.M., MacFADYEN, B. V., jr., DUDRICK, S.J.: Intravenous hyperalimentation in cancer patients. J. Surg. Res. 16, 241 (1974).PubMedCrossRefGoogle Scholar
  8. 8.
    COPELAND, E.M., MacFADYEN, B. V. jr., DUDRICK, S.J.: Prevention of microbial catheter contamination in patients receiving parenteral hyperalimentation. Sth. med. J. 67, 303 (1974).CrossRefGoogle Scholar
  9. 9.
    COPELAND, E.M., MacFADYEN, B. V., jr., LANZOTTI, V.J., DUDRICK, S.J.: Intravenous hyperalimentation as an adjunct to cancer chemotherapy. Amer. J. Surg. 1975 (In press).Google Scholar
  10. 10.
    COPELAND, E.M., MacFADYEN, B. V., jr., MacCOMB, W. S., GUILLAMONDEGUI, O., JESSEE, R. A., DUDRICK, S.J.: Intravenous hyperalimentation in patients with head and neck cancer. Cancer 1975 (In press).Google Scholar
  11. 11.
    COPELAND, E.M., MacFADYEN, B. V., jr., MacGOWN, C., DUDRICK, S.J.: The use of hyperalimentation in patients with potential sepsis. Surg. Gynec. Obstet. 38, 377 (1974).Google Scholar
  12. 12.
    CURRY, C.R., QUIE, P.G.: Fungal septicemia in patients receiving parenteral hyperalimentation. New Engl. J. Med. 285, 1221 (1971).PubMedCrossRefGoogle Scholar
  13. 13.
    DEMOPOULOS, H.B.: Effects of reducing phenylalanine-tyrosine intake of patients with advanced malignant melanoma. Cancer 19, 657 (1966).PubMedCrossRefGoogle Scholar
  14. 14.
    DeWYS, W.D.: Systemic effects of cancer: cachexia-anorexia. Abstracts of the XI. International Cancer Congress 1, 145 (1974).Google Scholar
  15. 15.
    DEY, M.G., RAMALINGASWAMI, V.: Reaction of the small intestine to induced protein malnutrition in rhesus monkeys -a study of cell population kinetics in the jejunum. Gastroenterology 49, 150 (1965).Google Scholar
  16. 16.
    DUDRICK, S.J., COPELAND, E.M.: Parenteral Hyperalimentation. Surgery Annual 1973 (ed. L. M. NYHUS), p. 69. Appleton-Century-Crofts.Google Scholar
  17. 17.
    HEATLEY, R.V., HUGHES, L.E.: Preoperative intravenous nutrition in cancer patients. Abstracts of the XI. International Cancer Congress 4, 874 (1974).Google Scholar
  18. 18.
    HUGON, J.S., BOUNOUS, G.: Elemental diet in the management of intestinal lesions produced by radiation in the mouse. Can. J. Surg. 15, 18 (1972).PubMedGoogle Scholar
  19. 19.
    MEYER, J.A.: Potentiation of solid-tumor chemotherapy by metabolic alteration. Ann. Surg. 179, 88 (1974).PubMedCrossRefGoogle Scholar
  20. 20.
    McKEE, R.W., LOMBERG-HOLM, K., JEHL, J.A.: Substrate utilization by Ehrlich mouse ascites carcinoma cells. Cancer Res. 13, 537 (1953).PubMedGoogle Scholar
  21. 21.
    SOUCHON, E.A., COPELAND, E.M., WATSON, P., DUDRICK, S. J. Intravenous hyperalimentation as an adjunct to cancer chemo therapy with 5-fluorouracil. J. Surg. Res. 1975 (In press).Google Scholar
  22. 22.
    WARBURG, O., POSENER, K., NEGELEINE, E.: Über den Stoffwech sel der Karzinomzelle. Biochem. Zeitschr. 152, 309 (1924)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1977

Authors and Affiliations

  • S. J. Dudrick
  • E. M. Copeland
  • B. V. MacFadyen

There are no affiliations available

Personalised recommendations